Becton, Dickinson and Company

NYSE:BDX

Medical - Instruments & Supplies

Healthcare
$216.08 +1.67%

+$2.36 today

Market cap
$58.86B
Beta
0.28
P/E (TTM)
35.5
EPS (TTM)
$4.06
Dividend yield
2.60%
52W Low $127.59High $187.35

Volume 1.32M

Average 2.76M

BDX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Becton, Dickinson and CompanyNYSE: BDX

Gross Margin · Q4 FY2026 · quarter ended Sep 2026

Gross margin widens to 51.1%

Gross margin was 51.1% in Q4 FY2026, up 3.6 pp from a year earlier. On a trailing-twelve-month basis it was 47.0%, up 1.6 pp year over year. Over 3 fiscal years it widened by 5.2 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
51.1%+4.6 pp QoQ
Last fiscal yearSep 2026
47.4%+1.9 pp YoY
LTMSep 2026
47.0%+1.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.6 pp——
1 year+1.9 pp——
3 years+5.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
47.4%
Year-over-year change
+1.9pp

Gross Margin vs competitors

How BDX compares with its peers on the latest reported figures

  • BDX's LTM Sep 2026 gross margin of 47.0% is the 8th highest of the 11 companies compared; the peer median is 54.2%.
  • Its year-over-year change of +1.6 pp is the 4th highest of 11, against a peer median of +0.6 pp.
  • Over three fiscal years its change of +5.2 pp compares with a peer median of +0.4 pp.
BDX Competitors Peer median
Gross Margin for BDX and competitors
Company Period LTM level YoY 3-year change
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
BLFSBioLife Solutions, Inc.LTM Mar 202663.9% -19.5 pp+3.0 pp
EMBCEmbecta Corp.LTM Mar 202662.5% -1.2 pp-5.7 pp
ABTAbbott LaboratoriesLTM Sep 202657.1% +3.1 pp+4.4 pp
SOLVSolventum CorporationLTM Jun 202654.7% +0.2 pp-4.3 pp
TFXTeleflex IncorporatedLTM Jun 202653.8% -1.8 pp+1.4 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202649.4% +0.9 pp+3.6 pp
BDXBecton, Dickinson and CompanyLTM Sep 202647.0% +1.6 pp+5.2 pp
ICUIICU Medical, Inc.LTM Jun 202637.6% +1.7 pp+6.2 pp
WSTWest Pharmaceutical Services, Inc.LTM Jun 202636.8% +1.4 pp-3.6 pp
BAXBaxter International Inc.LTM Jun 202630.1% -5.2 pp-5.2 pp
Peer median (excluding BDX) 54.2%+0.6 pp+0.4 pp

Competitors are the stored peer set for BDX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Revenue18.87B19.37B20.18B21.84B19.46B
Cost of Revenue10.39B11.2B11.05B11.92B10.24B
Gross Profit8.48B8.17B9.13B9.92B9.21B
Gross Margin44.9%42.2%45.2%45.4%47.4%
Research & Development1.26B1.24B1.19B1.26B988M
Selling, General & Admin4.71B4.72B4.86B5.28B4.97B
Operating Expenses6.2B6.06B6.73B7.35B6.96B
Depreciation & Amortization2.23B2.29B2.29B2.46B2.24B
EBITDA4.41B4.4B4.82B4.96B4.61B
EBITDA Margin23.4%22.7%23.9%22.7%23.7%
Operating Income2.28B2.11B2.4B2.58B2.26B
Operating Margin12.1%10.9%11.9%11.8%11.6%
Interest Income16M49M163M38M27M
Interest Expense398M452M528M613M564M
Other Income / Expenses(499M)(449M)(392M)(696M)(451M)
Income Before Tax1.78B1.66B2.01B1.88B1.81B
Pre-Tax Margin9.4%8.6%9.9%8.6%9.3%
Income Tax Expense148M132M300M204M388M
Net Income1.78B1.48B1.71B1.68B1.15B
Net Margin9.4%7.7%8.4%7.7%5.9%
EPS (Basic)5.934.975.885.844.11
EPS (Diluted)5.884.945.865.834.09
Weighted Avg Shares285.01M286.28M289.76M286.61M278.49M
Weighted Avg Shares (Diluted)287.36M288.39M291.01M287.12M279.94M

Becton, Dickinson and Company

NYSE:BDX

Intrinsic Alpha fair value

Locked

Current Price

$216.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.